Noteworthy, these overall actions of GLP-1 RAs against systemic inflammation, vascular damage, and atherosclerosis have been replicated in several experimental studies with patients with metabolic syndrome and T2DM [78]. Here, GLP1R is linked to type 2 diabetes mellitus.